← Eichor
Study identifier: NCT06596772 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis

Condition: Rheumatoid Arthritis (RA)  ·  Sponsor: mAbxience Research S.L.

PhasePhase 3
Planned participants458
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

A study to compare efficacy, pharmacokinetics, safety and immunogenicity of MB04 \[proposed etanercept biosimilar\] to Enbrel® \[EU-sourced\] in rheumatoid arthritis

This description comes directly from the study's public registry record.

Talk to the study team

Susana Millan, PhD  ·  +34-917-711-500  ·  Susana.Millan@mabxience.com

Amalia Flórez  ·  +34-917-711-500  ·  amalia.florez@mabxience.com

Always discuss trial participation with your own doctor first.

Locations (60)

Research site 2007Haskovo, BulgariaRecruiting
Research site 2005Plovdiv, BulgariaRecruiting
Research Site 2002Rousse, BulgariaRecruiting
Research site 2001Sofia, BulgariaRecruiting
Research Site 2003Sofia, BulgariaRecruiting
Research Site 2008Sofia, BulgariaRecruiting
Research site 2004Vidin, BulgariaRecruiting
Research site 2006Vratsa, BulgariaRecruiting
Research site 7004Batumi, GeorgiaRecruiting
Research site 7010Batumi, GeorgiaRecruiting
Research site 7001Tbilisi, GeorgiaRecruiting
Research site 7002Tbilisi, GeorgiaRecruiting

+ 48 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06596772